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Abstract 0 Low molecular weight homogeneous peptides were used
to form peptide/DNA condensates. A peptide possessing 18 lysines
was found to protect plasmid DNA from serum endonuclease and
sonicative-induced degradation whereas a shorter peptide possessing
8 lysines dissociated in 0.1 M sodium chloride and failed to protect
DNA from enzymatic degradation. Peptide-condensed DNA showed
no change in the ratio of supercoiled to circular DNA following 100 W
sonication for up to 60 s and was able to transfect HepG2 cells with
equivalent efficiency as untreated condensed plasmid DNA. Alter-
natively, uncondensed plasmid DNA was rapidly fragmented by
sonication and serum endonucleases and resulted in negligible gene
expression following condensation with peptide. Cationic lipid/DNA
complexes were only partially effective at stabilizing DNA in serum
compared to the complete stabilization afforded by peptide/DNA
condensation. These results indicate that the stabilization afforded
by condensation with a peptide protects DNA during formulation and
preserves its structure in serum. These functions are important to
achieve optimal gene expression from a nonviral gene delivery system.
Introduction
The development of optimized plasmid DNA dosage
forms for gene therapy requires an understanding of DNA
stability during formulation and during transport to the
target site.1 To accomplish optimal and prolonged gene
expression the delivery vehicle plays an important role in
protecting DNA from physical, chemical, and enzymatic
destruction. Delivery vehicles that bind to DNA and
facilitate transport to cellular targets include peptides,2
glycopeptides,3 glycosylated polymers,4,5 cationic lipids,6-10
liposomes,11,12 and PLGA microspheres.13
During fabrication of a delivery system the structure of
DNA can be altered by shear stress to convert supercoiled
plasmid to open circular, linear, or even fragmented DNA.8
Shear stress generated by ultrasonication is a common
approach used to minimize the particle size of a colloidal
drug delivery system. Despite its ability to fragment DNA,
several previous studies have used sonication as a means
to increase the uptake of DNA by cells or to reduce particle
size of colloidal DNA delivery systems.14-16 The transfer
of plasmid DNA into yeast cells in culture was reported to
be improved 20-fold using mild sonication (2 W) for 30 s
although further sonication led to significant DNA frag-
mentation and a decrease in the transfection efficiency.14
Higher intensity sonication was reported to improve the
encapsulation efficiency of DNA into liposomes, but the
stability of the encapsulated plasmid DNA was only
examined by low resolution gel permeation chromatogra-
phy.15 A cationic lipid/DNA formulation was also recently
reported to be stable to 50 W sonication for 60 s to reduce
particle size heterogeneity.16
Likewise, serum endonucleases can act in vivo during
transport to fragment unprotected DNA and thereby abol-
ish its ability to transform cells. Only a few studies have
examined the role of the drug delivery vehicle in stabilizing
DNA formulations in serum.1,6,17 Uncomplexed plasmid
DNA was found to be rapidly fragmented within 5 min in
vivo and within 30 min during in vitro incubation in mouse
serum due to the action of endogenous endonucleases.1,17
Certain cationic lipid/DNA complexes were reported to
partially protect DNA against purified DNAse I and
against DNAase in human serum despite reports that
cationic lipid gene transfer is greatly reduced in the
presence of serum.6,18
Gel electrophoresis is still the most direct and sensitive
approach to examine the stability of plasmid DNA in a gene
delivery formulation or in serum. However, peptide and
lipid delivery vehicles remain bound to DNA and interfere
with its migration thereby necessitating phenol/chloroform
extraction of DNA prior to electrophoresis. Other methods
of analyzing DNA stability, such as gel permeation chro-
matography or the transformation of Escherichia coli or
mammalian cells with extracted DNA, are less definitive
compared to the direct analysis of DNA stability by gel
electrophoresis since subtle alterations in DNA structure
may escape detection.14-16
The stability profile of DNA formulations containing
peptides and glycopeptides has not been reported previ-
ously. Partly, this is because of the difficulty of recovering
DNA from tightly bound peptides which inhibit migration
on gel electrophoresis. In the present study we have
examined the influence of plasmid structure in relationship
to gene expression in a peptide-mediated gene delivery
system. The results not only establish important meth-
odology that allow direct analysis of DNA stability by gel
electrophoresis, but also report that peptide/DNA conden-
sates are stable to sonicative shear stress and direct attack
from serum endonucleases. These properties help to
explain how peptide/DNA condensates are able to trans-
form cells in culture in the presence of serum and suggest
that a similar stability will be realized in vivo.
* To whom correspondence should be addressed, tel: 313-763-1032,
fax: 313-763-2022, email: krice@umich.edu.
† Divisions of Pharmaceutics and Medicinal Chemistry.
‡ Department of Pathology.
S0022-3549(98)00047-1 CCC: $15.00678 / Journal of Pharmaceutical Sciences © 1998, American Chemical Society and
Vol. 87, No. 6, June 1998 American Pharmaceutical AssociationPublished on Web 05/02/1998
Materials and Methods
CWK8 (Alkylated Cys-Trp-Lys8), CWK18 (Alkylated Cys-Trp-
Lys18), and dimeric CWK18 (K18WC-CWK18) were synthesized and
characterized as described previously.19 pCMVL was produced in
E. coli and purified using a Qiagen Ultrapure-100 kit (Santa
Clarita, CA). TPCK-treated trypsin was obtained from Worthing-
ton Biochemicals (Freehold, NJ). Micro BCA protein assay reagent
kit was obtained from Pierce (Rockford, IL). MEM, bovine calf
serum, electrophoresis grade agarose, and LipofectAce (1:2.5 w/w
dimethyldioctadecyammonium bromide and dioleolylphosphatid-
ylethanolamine) were obtained from Gibco BRL (Gaithersburg,
MD). Nru I restriction enzyme was purchased from Boehringer
Mannhein (Indianapolis, IN).
Generation of Linear and Circular pCMVLsSupercoiled
plasmid pCMVL19 was linearized with Nru I which recognizes the
sequence TCG/CGA at bp 206 of the pRC/CMV cloning vector from
Invitrogen (San Diego, CA). One hundred units of Nru I was used
to cleave 100 µg of pCMVL in 200 µL of SuRE/Cut buffer at 37 °C
for 1 h. The linear DNA was purified by precipitation with 150
µL of ethanol at -20 °C followed by centrifugation at 13000 g for
5 min at 4 °C and then analyzed by 1% agarose gel electrophoresis.
Open circular pCMVL was prepared by creating single stranded
nicks in the supercoiled pCMVL. The DNA (100 µg) was heated
to 70 °C in 100 µL of TAE buffer, pH 8.0, for 1 h and then purified
using ethanol precipitation and analyzed by gel electrophoresis.
Preparation and Characterization of Peptide/DNA
CondensatessPeptide/DNA condensates were prepared at a DNA
concentration of 50 µg/mL in 5 mM Hepes pH 7.4 using a
stoichiometry of 0.3 nmol of peptide per µg of DNA. DNA (150 µL
of 0.1 µg/µL) was added dropwise to a microfuge tube containing
4.5 nmol of peptide in 150 µL of buffer. Peptide/DNA condensates
formed instantly, although physical measurements were carried
out after 30 min to allow the particle size to stabilize.19 Particle
size analysis was performed on 350 µL of the undiluted DNA/
peptide complex using a Nicomp 370 Autodilute Particle Sizer
(Nicomp, Santa Barbara, CA).
Sonication of DNA CondensatessA 100 W Microson XL-
2000 ultrasonic probe homogenizer (Kontes, Vineland, NJ) with
a vibrational amplitude of 5 was used throughout the study. The
probe tip was placed at 3/4 depth into a 1.5 mL microfuge tube
containing 300 µL of sample. The sonication time was varied from
15 to 60 s, and the probe tip was washed between samples using
deionized water.
Sonicated DNA samples were analyzed by gel electrophoresis
on a 1% agarose gel prepared in TAE buffer (pH 8.0, 40 mM Tris
acetate, 2 mM EDTA) containing 0.5 mg/mL ethidium bromide.
Prior to electrophoresis, peptide/DNA condensates (2.5 µg DNA)
were digested for 30 min with 5 µg of trypsin (0.2 units) prepared
in a final volume of 50 µL of 5 mMHepes pH 7.4 in order to release
plasmid DNA from the condensate. The DNA (0.75 µg/15 µL) was
combined with 3 µL of loading buffer (0.25 wt % bromophenol blue,
0.25 wt % xylene cyanol FF, and 30 wt % glycerol in water) and
then loaded onto the gel and electrophoresed for 1.5 h at 70 V.
DNA bands were visualized following destaining of the ethidium
bromide on a transilluminator and photographed on Polaroid 667
black and white film.
DNA condensates were prepared using either CWK8, CWK18
or dimeric-CWK18 and then adjusted to 0.1, 0.2, 0.3, 0.4, 0.6, 0.8,
and 1 M sodium chloride and sonicated for 60 s to fragment
uncondensed DNA. The samples were then digested with trypsin
and electrophoresed on an agarose gel.
Serum Stability of Peptide/DNA CondensatessThe DNAse
activity in freshly prepared mouse serum was determined to be
4.2 units/µL according to the method of Kunitz.20 CWK18/DNA
condensates (5 µg/100 µL) prepared in 5 mM Hepes pH 7.4 and
150 mM sodium chloride were combined with 100 µL of mouse
serum and allowed to incubate at 37 °C for 3 h, while rapidly
freezing 10 µL aliquots at intermediate time points. Prior to
electrophoresis, 10 µL of 10 mg/mL SDS was added to each aliquot
along with 5 µL of 68 mM EDTA and 3 µL of loading buffer, and
samples were applied to an agarose gel containing 0.05 w/v% SDS
and electrophoresed for 1 h at 70 V. The gel was destained in
water for 24 h to remove SDS and increase the detection of the
bands by ethidium bromide.
The stability of a LipofectAce/DNA complex was also studied
by combining 30 µL of LipofectAce with 20 µL of 5 mM Hepes
containing 150 mM sodium chloride and 50 µL of DNA (10 µg/100
µL of 5 mM Hepes pH 7.4). The complexes were then combined
with 100 µL of mouse serum, incubated at 37 °C for 3 h while
removing time points, and then electrophoresed as described above
for peptide/DNA condensates.
In Vitro Gene TransfersGene transfer experiments were
performed on HepG2 cells grown to 40% confluence in MEM
supplemented with 10% fetal bovine serum as reported previ-
ously.19 The DNA condensate (10 µg of DNA) was applied to the
cells in 2% fetal bovine serum with 80 µM chloroquine and allowed
to incubate for 5 h after which time the media was replaced with
MEM containing 10% fetal bovine serum.19 After 24 h, cells were
harvested and analyzed for the presence of luciferase. The
expression level of luciferase was normalized for protein in each
well, and the relative light units were converted to fmol of
luciferase/mg of protein using a standard curve as reported
previously.19 Each experimental result represents the mean and
standard deviation derived from a triplicate set of transfections.
Results
To establish a relationship between plasmid DNA struc-
ture and gene transfer efficiency, we first prepared circular
DNA by base hydrolysis of supercoiled DNA. In its native
form, plasmid DNA exists as a mixture of both supercoiled
and open circular DNA forms that resolve on gel electro-
phoresis (Figure 1, lane 1). Treatment of plasmid DNA at
pH 8.0 with elevated temperature (70 °C) accelerated the
hydrolysis of supercoiled DNA to form predominantly
circular DNA within 2 h (Figure 1A, lane 2). Linear DNA
was prepared by restriction digestion with Nru I, which
cleaved the plasmid prior to the CMV promoter, leaving
the essential coding region for luciferase and the CMV
promoter intact (Figure 1, lane 3).
Condensation of DNA with peptides possessing lysine
repeats of either 18 or 36 residues resulted in the formation
of fully condensed 50-70 nm diameter particles.19 Linear,
supercoiled, and circular DNA condensates could not be
distinguished through particle size on QELS analysis
(Table 1). However, their transfection efficiency was
significantly different (Figure 2). The gene transfer ef-
ficiency of circular DNA was only reduced 10% compared
to supercoiled DNA whereas linear DNA condensates were
nearly 90% less efficient at transfecting cells and uncon-
densed DNA was inactive in mediating expression.
We then analyzed the influence of shear stress and
endonuclease attack on the stability of supercoiled plasmid
Figure 1sGel electrophoresis of supercoiled, circular, and linear DNA. The
result of converting supercoiled pCMVL (lane 1) to open circular (lane 2) and
linear (lane 3) DNA is shown. Each lane was loaded with 0.5 µg of DNA and
electrophoresed as described in Materials and Methods. The result of gene
transfer with each type of DNA is described in Figure 2.
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DNA. Condensed and uncondensed DNA were challenged
with 100 W sonication for up to 60 s. Sonication of
uncondensed plasmid DNA for as little as 15 s resulted in
extensive fragmentation (Figure 3, lane 2), while prolonged
sonication for 30-60 s further fragments DNA to form a
finite size distribution of oligonucleotides as previously
reported (Figure 3, lanes 3 and 4).21
In contrast, electrophoretic analysis of peptide condensed
DNA sonicated for 60 s resulted in an empty lane (Figure
3, lane 5). This results from the failure of peptide/DNA
condensates to dissociate and to stain with ethidium
bromide. Trypsin was used to hydrolyze CWK18, allowing
the plasmid DNA to migrate and stain normally in the gel
(Figure 3, lane 6). The formation of 10% linear DNA was
the result of endonuclease contamination of trypsin. This
was deduced from control experiments in which trypsin
digestion of peptide/DNA condensates as well as uncon-
densed plasmid DNA both produced a linear DNA band
(Figure 3, lane 7 and 8).
Peptide/DNA condensates were sonicated for up to 60 s
and used to transfect HepG2 cells to establish that soni-
cation also does not alter gene transfer efficiency. The
results showed no change in gene transfer efficiency for
sonicated DNA relative to unsonicated condensates (Figure
4). Fragmented DNA also formed small (45 nm) peptide/
DNA condensates (Table 1), but these showed negligible
gene expression activity (Figure 4).
Since the stability of peptide/DNA condensates may also
be influenced by the solution ionic strength, we analyzed
the dissociation of peptide/DNA condensates in the pres-
ence of increasing sodium chloride concentration in an
attempt to disrupt the peptide/DNA binding. However, the
failure to detect any DNA bands by gel electrophoresis after
incubating the condensates with up to 5 M sodium chloride
suggested that either the condensates failed to dissociate
or they reformed during gel electrophoresis.
To distinguish between these alternatives, peptide/DNA
condensates were treated with sodium chloride at concen-
trations ranging from 0 to 1 M and then sonicated for 60 s
to fragment any uncondensed DNA. Trypsin was then
added to hydrolyze CWK18 and allow the DNA to migrate
into the gel during electrophoresis. The resulting gel
established that peptide/DNA condensates dissociate at
sodium chloride concentrations below 1 M as revealed by
the presence of fragmented DNA (Figure 5).
The validity of the method was established by comparing
the sodium chloride concentration required to dissociate
three different peptides. Previously, we established that
CWK8 binds weakly to DNA but was able to fully condense
DNA at a stoichiometry of 0.8 nmol per µg of DNA.19 As
observed in Figure 5A, the DNA remains protected by
CWK8 in 0.1 M sodium chloride (lane 2) but was degraded
by sonication at all higher sodium chloride concentrations
due to dissociation of the peptide/DNA complex. CWK18
possesses a significantly greater affinity for DNA resulting
in complete condensation at 0.3 nmol per µg of DNA.18 The
Table 1sParticle Size Analysis of Peptide/DNA Condensatesa
particle size population





a Peptide/DNA condensates were prepared at a concentration of 50 µg/
mL of DNA and at stoichiometry of 0.3 nmol of CWK18 per µg of DNA.
b Represents the mean diameter of particles. c Standard deviation of the
population. d DNA sonicated for 60 s prior to condensation with CWK18.
Figure 2sGene transfer efficiency of supercoiled, circular, and linear DNA.
The transfection efficiency of the three types of DNA shown in Figure 1 were
compared. Each transfection utilized 10 µg of DNA combined with 3 nmol of
CWK18 in 200 µL of 5 mM Hepes pH 7.4. The results establish a slight (10%)
reduction in gene transfer when using open circular DNA and a 90% reduction
when the DNA is linear relative to supercoiled DNA. Identical transfections
with uncondensed DNA only resulted in 0.001 fmol of luceriferase per mg of
protein.
Figure 3sStability of peptide/DNA condensates to ultrasonication. Gel
electrophoresis with ethidium staining was used to demonstrate the fragmenta-
tion of plasmid DNA on sonication for 15, 30, and 60 s (lanes 2, 3, and 4)
relative to standard DNA (lane 1). After complexation with CWK18 and
sonication for 60 s, plasmid DNA failed to migrate on gel electrophoresis
(lane 5). Treatment of the sonicated condensed DNA with trypsin restored
migration but led to the formation of some linear DNA (lane 6). Omission of
sonication (lane 7) or both sonication and condensation with CWK18 (lane 8)
resulted in identical banding patterns indicating that linear DNA was an artifact
of contaminated trypsin.
Figure 4sGene transfer efficiency of sonicated peptide/DNA condensates.
The expression of luciferase following in vitro transfection of HepG2 cells is
compared for CWK18/DNA condensates subjected to 0, 15, 30, and 60 s of
sonication, relative to plasmid DNA sonicated for 60 s and then condensed
with CWK18 (open bar).
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results shown in Figure 5B support this by demonstrating
protection of the DNA by CWK18 at concentrations up to
0.4 M sodium chloride. Likewise, dimeric-CWK18 was
previously found to have a slightly higher affinity for DNA
but produced condensates that were the same size as
CWK18.19 In agreement with these results, dimeric-CWK18/
DNA condensates were more stable as demonstrated by
their ability to resist sonicative-induced fragmentation up
to 0.6 M sodium chloride.
To study the serum stability of peptide/DNA condensates
required modification of the gel electrophoresis approach.
In the presence of serum, trypsin was incapable of com-
pletely hydrolyzing the peptide to release DNA, resulting
in bands that migrated slower than open circular DNA on
gel electrophoresis (data not shown). Consequently, SDS
was found to be an effective agent to dissociate the peptide/
DNA complexes present in serum. The optimal result was
obtained by adding 0.05 w/v% of SDS in the agarose gel
and running buffer along with 0.3 w/v% SDS in the loading
lane.
Incubation of either DNA, peptide/DNA condensates, or
LipofectAce/DNA complexes with freshly prepared mouse
serum adjusted to 0.15 M sodium chloride was used to
establish the in vitro stability of DNA. Direct analysis of
the incubation time points by SDS-agarose electrophoresis
established that uncondensed DNA rapidly converted from
supercoiled to circular DNA and then began to form linear
DNA within a 5 min incubation period (Figure 6A, lane
2). Further incubation resulted in progressive formation
of linear DNA which then degraded to smaller oligonucle-
otides within 1 h and resulted in complete fragmentation
of DNA within 3 h (Figure 6A, lanes 6-8). Conversely,
CWK18 condensed DNA was stable when exposed to serum
during a 3 h incubation period (Figure 6B), demonstrating
the complete preservation of supercoiled DNA.
This result suggested that the dissociation of CWK8/DNA
condensates in normal saline (0.15 M) could leave DNA
exposed to serum endonucleases. Incubation of CWK8/DNA
condensates with serum resulted in a degradation profile
that was identical to that observed for uncondensed DNA
(Figure 6C). This adequately explains the three-orders of
magnitude difference in the transfection efficiency previ-
ously observed when transfecting cells with CWK18 and
CWK8/DNA condensates in the presence of fetal calf
serum.19
This same rational may also explain the ineffectiveness
of LipofectAce/DNA transfection in the presence of serum.
To establish this point, LipofectAce/DNA complexes were
incubated in serum, and time points ranging from 0 to 3 h
were analyzed by gel electrophoresis (Figure 6D). Although
some protective effect was conferred by the presence of the
cationic lipid formulation, the DNA still underwent a
complete conversion from supercoiled to circular and linear
DNA within 1 h and was 50% depolymerized during the 3
h incubation.
Discussion
The stability of a DNA formulation in serum is funda-
mental to its successful application in vivo since premature
metabolism results in the generation of fragmented DNA
which lacks gene transfer potency. The utility of gel
electrophoresis to study the stability of plasmid DNA
complexed with peptides or lipids in a gene delivery
formulation has been limited because of the interference
imparted by the these biopolymers which retard or distort
the electrophoretic migration of DNA. The present results
establish that the addition of SDS to agarose gel electro-
phoresis or, the use of trypsin to remove peptide, allow
direct analysis of the status of DNA in a complex formula-
tion and in serum. The use of radiolabeled DNA will
further advance these studies by allowing a quantitative
analysis of DNA recovery.
In an effort to understand how the serum stability of
peptide/DNA condensates correlates with gene expression,
we first analyzed how changes in plasmid structure influ-
ence gene transfer efficiency. The results presented in
Figures 1 and 2 demonstrate that the conversion of DNA
from supercoiled to circular only has a minor effect on the
gene transfer efficiency. However, subsequent conversion
to linear DNA reduces gene expression by 90% whereas
transformation to oligonucleotide fragments via sonication
reduced gene expression nearly 1000-fold (Figure 2).
We were intrigued to find that high-intensity sonication
of CWK18/DNA condensates for up to 60 s failed to degrade
the DNA (Figure 3). It is also interesting that sonicatively
fragmented DNA was still able to bind to CWK18 and
produce condensates that were indistinguishable in size
relative to those prepared from supercoiled, circular, or
linear DNA (Table 1). Thus, it is evident that the poor
transfection performance of fragmented DNA is not because
of the failure to form condensate but rather directly related
to the stability of the DNA.
We cannot explain the mechanism by which DNA folds
to produce particles of a defined size, but it must be
Figure 5sSodium chloride induced dissociation of peptide/DNA condensates. The stability of peptide/DNA condensates to sonication in the presence of 0−1 M
sodium chloride is demonstrated using gel electrophoresis. CWK8 (panel A), CWK18 (panel B), and dimeric-CWK18 (panel C) DNA condensates were treated with
0.1, 0.2, 0.3, 0.4, 0.6, 0.8, and 1 M sodium chloride prior to 60 s sonication and trypsin digestion. The dissociation of the peptide/DNA condensate was observed
at above 0.1 M for CWK8 (panel A), above 0.4 M CWK18 (panel B), and above 0.6 M for dimeric-CWK18 (panel C) DNA condensates.
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intrinsically related to the nature of peptide rather than
the size or polydispersity of the DNA since it is clear that
peptide size influences the properties of condensates.19,22
A practical outcome of this analysis of peptide/DNA stabil-
ity is that high power sonication could be used as a means
to reduce particle size while still preserving DNA structure
when developing complex formulations for gene therapy
that require shear stress, such as liposomes18 or aerosols.8
The dissociation of peptide/DNA complexes in sodium
chloride allowed for the development of an assay to define
the condensation status of DNA in a complex solution. The
data presented in Figure 5 clearly demonstrate that the
dissociation of peptide from DNA at a defined salt concen-
tration depends on the affinity of different peptides binding
to DNA. The data not only established that CWK18 retains
its ability to bind to DNA in 0.4 M sodium chloride but
also revealed that CWK8 dissociates at a concentration of
0.1 M sodium chloride. These results predicted that CWK18
would protect DNA from endonucleases in normal saline
(0.15 M sodium chloride) whereas CWK8 would not protect
DNA. This proved to be the case, in that there was no
distinction between DNA serum stability in the presence
or absence of CWK8 whereas the complete protection of
DNA was observed when complexed with CWK18 (Figure
6).
An examination of the serum stability of LipofectAce/
DNA complexes determined that the DNA was more stable
than uncondensed plasmid DNA but still degraded to
oligonucleotides within a couple of hours. These results
adequately explain the lack of potency when transforming
cells with uncondensed DNA and when using LipofectAce
in the presence of serum. Moreover, the data suggest a
possible explanation for the lack of correlation between in
vitro and in vivo gene transfer results for certain gene
delivery vehicles.
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